Publicaties

An International Expert-Based CONsensus on Indications and Techniques for aoRtic balloOn occLusion in the Management of Ruptured Abdominal Aortic Aneurysms (CONTROL-RAAA).
D’Oria M, Lembo R, Hörer TM, Rasmussen T, Mani K, Parlani G, Ierardi AM, Veraldi GF, Melloni A, Bonardelli S, Lepidi S, Bertoglio L; Collaborative CONTROL-RAAA Study Group.
J Endovasc Ther. 2023 Dec 7.

Post-Dissection Aortic Aneurysm Treated by In Situ Laser Fenestrated Endovascular Aortic Repair With Four Fenestrations.
Smet Nick, Van den Eynde Wouter. 
Eur J Vasc Endovasc Surg. 2023 Sep;66(3):396. Epub 2023 Jul 25.

Outcomes of Percutaneous Access to the First Versus Third Segment of Axillary Artery During Aortic Procedures.
Melloni A, Bertoglio L, Van den Eynde W, Agrusa CJ, Parlani G, Howard DPJ, Rio J, Fazzini S, Mansour W, Dias NV, Ronchey S, Branzan D; SUPERAXA and PAXA Registry Collaborators *.
J Endovasc Ther. 2023 Sep 26.

Multicentre International Registry of Open Surgical Versus Percutaneous Upper Extremity Access During Endovascular Aortic Procedures.
Bertoglio L, Oderich G, Melloni A, Gargiulo M, Kölbel T, Adam DJ, Di Marzo L, Piffaretti G, Agrusa CJ, Van den Eynde W and SUPER-AXA Registry Collaborators.
Eur J Vasc Endovasc Surg. 2023 Feb 3:S1078-5884(23)00080-1.

PRINciples of optimal antithrombotiC therapy and coagulation managEment during elective fenestrated and branched EndovaScular aortic repairS (PRINCE2SS): An International Expert Based Delphi Consensus Study 
D’Oria M, Bertoglio L, Bignamini AA, Mani K, Kolbel T, Oderich G, Chiesa R, Lepidi S; of the PRINCE(2)SS collaborative study group.
Eur J Vasc Endovasc Surg. 2022 Mar 12: S1078-5884(22)00143-5. 

Treatment of aortoesophageal fistula after endovascular aortic repair for mycotic thoracic aneurysm secondary to endoscopic botulinum toxin injections;
Michael Huysmans, Jurgen Verbist, Wouter Van den Eynde, Fien Gryffroy, Koen Vermeiren, Pieter-Jan Cuyle.
Annals of Vascular Surgery – Brief Reports and Innovations, 29 January 2022, Volume 2, Issue 1;

Percutaneous transAXillary access for endovascular aortic procedures in the multicenter international PAXA registry.
Bertoglio L, Conradi L, Howard DPJ, Kaki A, Van den Eynde W, Rio J, Montorfano M, Dias NV, Ronchey S, Parlani G, Chiesa R, Schewel J; of the PAXA Collaborators.
J Vasc Surg. 2021 Sep 30:S0741-5214(21)02154-6.

Thirty-day Results from the ZEPHYR Registry: Outcomes of EVAR Using the Zenith Alpha™ Abdominal Endovascular Graft for the Treatment of AAA in 347 Patients.
Hatzl J, Batenburg MVB, Yeung KK, Fioole B, Verhoeven E, Lauwers G, Kölbel T, Wever JJ, Scheinert D, Van den Eynde W, Rouhani G, Mees BME, Vermassen F, Schelzig H, Cuypers PWM, Böckler D; Zephyr study group collaborators.
Ann Vasc Surg. 2021 Aug 30:S0890-5096(21)00562-8.

Endovascular treatment of a primary aortoduodenal fistula.
De Smet A, Van den Eynde W, Peeters P, Verbist J.
J Cardiovasc Surg (Torino). 2018 Dec;59(6):844-845.

First implant takes place in Bolton Medical’s Treo Registry at Imelda Hospital Bonheiden.

A Growing Type I Thoraco-abominal Aneurysm after treatment with a Multilayer stent.
Van den Eynde W, Verbist J. 
Eur J Vasc Endovasc Surg. 2017 Jun 29

Endovascular repair of a type 1a endoleak after Ch-EVAR with a b-EVAR. 
Van den Eynde W, Van Breussegem A, Joos B, Keirse K, Verbist J, Peeters P.
Cardiovasc Intervent Radiol. 2016 Sep;39(9):1361-3.

Early Results from the ENGAGE Registry: Real-world Performance of the Endurant Stent Graft for Endovascular AAA Repair in 1262 Patients. 
Stokmans RA1, Teijink JA, Forbes TL, Böckler D, Peeters P, Riambau V, Hayes PD, van Sambeek MR.
Eur J Vasc Endovasc Surg. 2012 Oct;44(4):369-75. doi: 10.1016/j.ejvs.2012.07.005. Epub 2012 Jul 24.

Aorto-iliac stent graft infection complicated by endotension and consequent rupture of the aneurysmal sac: a case report.
Van den Eynde W, van Riel W, Nevelsteen A, Daenen G.
Acta Chir Belg. 2011 Jul-Aug;111(4):246-9.

Treatment of a left common iliac aneurysm with endovascular Powerlink stentgraft in a patient with an occlusion of a left common iliac stent.
Libeer F, Peeters P, Verbist J.
Acta Chir Belg. 2009 Nov-Dec;109(6):785-7.

Technical Challenges and Solutions for the Endovascular Treatment of a Complex Aortoiliac Occlusive Disease.
Bosiers M, Deloose K, Verbist J, Peeters P.
Endovascular Management of Aorto-iliac Complications 2008.

Complex thoracic aortic aneurysm: a combined open and endovascular approach.
Wolthuis AM, Houthoofd S, Deferm H, Haenen L, Verbist J, Peeters P.
Acta Chir Belg. 2005 Aug;105(4):400-2.

EVAR Patients with Challenging Iliac Arteries.
Peeters P, Bosiers M, Verbist J, Deloose K.
Endovascular Today 2003 May/June; Supplement 16-19.

Anatomical Criteria for Endovascular Abdominal Aortic Aneurysm Repair.
Peeters P, Bosiers M, Verbist J.
Journal Des Maladies Vasculaires. Vol 27, suppl 1, IS40, March 2002.

Two Year European Experience using a uni-body device (Endologix) for Endovascular AAA Exclusion.
Peeters P, Bosiers M, Verbist J, Deferm H, Haenen L, Vermaercke M, De Waele J, Deloose K.
Endocardiovascular WEB magazine. Vol 6, 2, June2002.

Endoleaks after endoluminal repair of abdominal aortic aneurysms: diagnosis and treatment.
Verbist J, Peeters P, Bosiers M, Deferm H, Haenen L, Vermaercke M, Vercaeren P.
Acta Chir Belg. 2001 Jul-Aug;101(4):149-54.

Succesful treatment of secondary aorto-esophageal fistula by use of silver impregnated aortic prosthesis and omental pedicle graft.
Keirse K, Peeters P, Verbist J, Bosiers M, Deloose K.
Journal of Cardiovasc Surgery 2003; 44: 43.

Spontaneous rupture of an aneurysm of the right subclavian artery as a first presentation of Ehlers Danlos syndrome in a 15-year old boy.
Verbert A, Verbist J, Peeters P, Deferm H, Haenen L.
Acta Chir Belg. 2013 Sep-Oct;113(5):367-72.

Dysphagia lusoria. Indications and surgical approaches for non-aneurysmatic aberrant right subclavian artery. 
Debonnaire G, Verbist J, Peeters P. 
Acta Chir Belg. 2012 May-Jun;112(3):237-9.

The role of carotid artery stenting for recent cerebral ischemia.
Bosiers M, Callaert J, Deloose K, Verbist J, Keirse K, Peeters P.
J Cardiovasc Surg (Torino). 2010 Jun;51(3):293-304.

Carotid stenting is a valuable alternative to carotid endarterectomy.
Bosiers M, Deloose K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2008 Dec;49(6):709-19.

What practical factors guide the choice of stent and protection device during carotid angioplasty?
Bosiers M, Deloose K, Verbist J, Peeters P.
Eur J Vasc Endovasc Surg. 2008 Jun;35(6):637-43.

The impact of embolic protection device and stent design on the outcome of CAS.
Bosiers M, Deloose K, Verbist J, Peeters P.
Perspect Vasc Surg Endovasc Ther. 2008 Sep;20(3):272-9.

What practical factors guide the choice of stent and protection device during carotid angioplasty?
Bosiers M, Deloose K, Peeters P, Verbist J.
Eur J Vasc Endovasc Surg. 2008 Jun;35(6):637-43.

Does free cell area influence the outcome in carotid artery stenting?
Bosiers M, de Donato G, Deloose K, Verbist J, Peeters P, Castriota F, Cremonesi A, Setacci C.
Eur J Vasc Endovasc Surg. 2007 Feb;33(2):135-41

Do device characteristics impact outcome in carotid artery stenting?
Hart JP, Peeters P, Verbist J, Deloose K, Bosiers M.
J Vasc Surg. 2006 Oct;44(4):725-30.

Review of stents for the carotid artery.
Bosiers M, Deloose K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2006 Apr;47(2):107-13.

Carotid artery stenting: which stent for which lesion?
Bosiers M, Deloose K, Verbist J, Peeters P.
Vascular. 2005 Jul-Aug;13(4):205-10.

Does carotid artery stenting work on the long run: 5-year results in high-volume centers (ELOCAS Registry).
Bosiers M, Peeters P, Deloose K, Verbist J, Sievert H, Sugita J, Castriota F, Cremonesi A.
J Cardiovasc Surg (Torino). 2005 Jun;46(3):241-7.

Endovascular treatment strategies for supra-aortic arterial occlusive disease.
Peeters P, Verbist J, Deloose K, Bosiers M.
J Cardiovasc Surg (Torino). 2005 Jun;46(3):193-200.

Selection of treatment for patients with carotid artery disease: medication, carotid endarterectomy, or carotid artery stenting.
Bosiers M, Peeters P, Deloose K, Verbist J, Sprouse RL 2nd.
Vascular. 2005 Mar-Apr;13(2):92-7.

Choice of protection devices in carotid angioplasty. Two case reports.
Hendrickx T, Verbist J, Peeters P.
Acta Chir Belg. 2004 Jun;104(3):357-60.

ZILVERPASS Study: ZILVER PTX Stent versus Prosthetic Above-the-Knee Bypass Surgery in Femoropopliteal Lesions, 5-year Results.
Bosiers MJ, De Donato G, Torsello G, Silveira PG, Scheinert D, Veroux P, Hendriks J, Maene L, Keirse K, Navarro T, Eckstein HH, Teβarek J, Giaquinta A, van den Eynde W, Verbist J, Callaert J, Deloose K, Bosiers M. Cardiovasc Intervent Radiol. 2023 Sep 5

ZILVERPASS Study: ZILVER PTX Stent vs. Bypass Surgery in Femoropopliteal Lesions, 3 year results and economic analysis.
Bosiers M, DE Donato G, Torsello G, Galvagni Silveira P, Deloose K, Scheinert D, Veroux P, Hendriks J, Maene L, Keirse K, Navarro T, Callaert J, Eckstein HH, Tessarek J, Giaquinta A, van den Eynde W, Verbist J, Wahl-Gravsen J, Bosiers MJ.J Cardiovasc Surg (Torino). 2023 Aug;64(4):413-421


One-year outcome of the everolimus eluting balloon-expandable Promus Element and Promus Element Plus stent in the treatment of below-the-knee lesions in CLI patients. 
Taeymans K, Bosiers M, Deloose K, Callaert J, Keirse K, Verbist J, Van den Eynde W, Torsello G, Wauters J.
J Cardiovascu Surg (Torino). 2020 Aug; 61 (4): 445-450

One-year outcome of the paclitaxel-eluting Legflow balloon catheter in the treatment of long and complex femoropopliteal lesions.Bosiers M, Deloose K, Torsello G, Scheinert D, Verbist J, van den Eynde W, Maene L, Beelen R, Keirse K, Hendriks J, Callaert J, Bosiers M, Wauters J.
J Cardiovasc Surg (Torino). 2020 Aug;61(4):471-477. doi: 10.23736/S0021-9509.20.11236-9. Epub 2020 Apr 1.

EVOLUTION Study: 12-month results.
Bosiers M, Deloose K, Callaert J, Peeters P, Verbist J, van den Eynde W, Maene L, Beelen R, Keirse K, Wauters J.
J Cardiovasc Surg (Torino). 2019 Aug;60(4):490-495. doi: 10.23736/S0021-9509.19.10706-9. Epub 2019 Jan 28.

BeGraft Peripheral PMCF Study: 12-month results.
Deloose K, Bosiers M, Callaert J, Peeters P, Verbist J, van den Eynde W, Maene L, Beelen R, Keirse K.
J Cardiovasc Surg (Torino). 2017 May 26

24-Month Data from the Bravissimo: A Large-scale Prospective Registry on iliac Stenting for TASC A & B and TASC C & D Lesions.
de Donato G, Bosiers M, Setacci F, Deloose K, Galzerano G, Verbist J, Peeters P, Setacci C.
Ann Vasc Surg. 2015;29(4):738-50

IVUS is not worth the cost for peripheral arterial disease interventions.
D Struyve, W Van den Eynde, J Verbist, P Peeters.
CX 14 Vascular and endovascular Challenges Update, Apr 2015.

Primary stenting is nowadays the golden standard treatment for TASC II A & B iliac lesions: The definitive MISAGO 1-year results.
Deloose K, Bosiers M, Callaert J, Verbist J, Vermassen F, Scheinert D, Torsello G, Peeters P.
J Cardiovasc Surg (Torino). 2014 Oct 21.

Popliteal artery aneurysm: when open, when endo? 
Gallala S, Verbist J, Van den Eynde W, Peeters P.
J Cardiovasc Surg (Torino). 2014 Apr;55(2 Suppl 1):239-47

Which is currently the best strategy for treatment of SFA in-stent restenosis? 
Elens M, Verbist J, Keirse K, Van den Eynde W, Peeters P.
J Cardiovasc Surg (Torino). 2014 Aug;55(4):477-81.

Refining stent technologies for femoral interventions. 
Bosiers M, Deloose K, Callaert J, Maene L, Keirse K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2012 Aug;53(4):465-73.

Endovascular procedures and new insights in diabetic limb salvage.
Peeters P, Verbist J, Keirse K, Callaert J, Deloose K, Bosiers M.
J Cardiovasc Surg (Torino). 2012 Feb;53(1):31-7.

Results of the Protégé Everflex 200 mm long nitinol stent (ev3) in TASC C and D femoropopliteal lesions. 
Bosiers M, Deloose K, Callaert J, Moreels N, Keirse K, Verbist J, Peeters P.
J Vasc Surg. 2011 Oct;54(4):1042-50.

Drug eluting stents below the knee. 
Bosiers M, Deloose K, Callaert J, Keirse K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2011 Apr;52(2):231-4

Prevention and treatment of in-stent restenosis.
Bosiers M, Deloose K, Keirs K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2010 Aug;51(4):591-8.

Endovascular management of acute limb ischemia.
Peeters P, Verbist J, Keirse K, Deloose K, Bosiers M.
J Cardiovasc Surg (Torino). 2010 Jun;51(3):329-36.

Are drug-eluting stents the future of SFA treatment?
Bosiers M, Deloose K, Keirse K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2010 Feb;51(1):115-9.

What is involved in offering an acute endovascular service?
Patrick Peeters, MD, Ozan Yazar, MD, Wouter Van den Eynde, MD, Jürgen Verbist, MD, Koen De Loose, MD, Marc Bosiers, MD.
Vascular and Endovascular Controversies Update, Charing Cross, 2010

Other endovascular methods of treating the diabetic foot.
Peeters P, Keirse K, Verbist J, Deloose K, Bosiers M.
J Cardiovasc Surg (Torino). 2009 Jun;50(3):313-21.

Update management below knee intervention.
Bosiers M, Deloose K, Verbist J, Peeters P.
Minerva Cardioangiol. 2009 Feb;57(1):117-29.

Present and future of endovascular SFA treatment: stents, stent-grafts, drug coated balloons and drug coated stents.
Bosiers M, Deloose K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2008 Apr;49(2):159-65.

Will heparin-bonded PTFE replace autologous venous conduits in infrapopleal bypass?
Peeters P, Verbist J, Bosiers M, Deloose K.
Italian Journal of Vascular and Endovascular Surgery 15(3):143-148 September 2008.

Results with heparin bonded polytetrafluoroethylene grafts for femorodistal bypasses.
Peeters P, Verbist J, Deloose K, Bosiers M.
J Cardiovasc Surg (Torino). 2006 Aug;47(4):407-13.

Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures.
Bosiers M, Hart JP, Deloose K, Verbist J, Peeters P.
Vascular. 2006 Mar-Apr;14(2):63-9.

Will absorbable metal stent technology change our practice?
Bosiers M, Deloose K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2006 Aug;47(4):393-7.

Percutaneous transluminal angioplasty for treatment of ”below-the-knee” critical limb ischemia: early outcomes following the use of sirolimus-eluting stents.
Bosiers M, Deloose K, Verbist J, Peeters P.
J Cardiovasc Surg (Torino). 2006 Apr;47(2):171-6.

Preliminary results after application of absorbable metal stents in patients with critical limb ischemia.
Peeters P, Bosiers M, Verbist J, Deloose K, Heublein B.
J Endovasc Ther. 2005 Feb;12(1):1-5.

Durability and efficacy of the ELVeS® Radial® 2ring slim fiber for multiple ablations.
Verbist J, Laeremans V, Gryffroy F, Van den Eynde W, Heerinckx C, Haesen D.Phlebology. 2023 Aug 6


Right sided Cockett’s Syndrome. 
Du Pont B, Verbist J, Van den Eynde W, Peeters P.
Acta Chir Belg. 2016 Apr;116(2):114-8.